These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 16216989)
21. Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction. Phrommintikul A; Tran L; Kompa A; Wang B; Adrahtas A; Cantwell D; Kelly DJ; Krum H Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1804-14. PubMed ID: 18245565 [TBL] [Abstract][Full Text] [Related]
22. Copper-induced reduction in myocardial fibrosis is associated with increased matrix metalloproteins in a rat model of cardiac hypertrophy. Liu Y; Xiao Y; Liu J; Feng L; Kang YJ Metallomics; 2018 Jan; 10(1):201-208. PubMed ID: 29302675 [TBL] [Abstract][Full Text] [Related]
24. Attenuation of aortic banding-induced cardiac hypertrophy by propranolol is independent of beta-adrenoceptor blockade. Marano G; Palazzesi S; Fadda A; Vergari A; Ferrari AU J Hypertens; 2002 Apr; 20(4):763-9. PubMed ID: 11910314 [TBL] [Abstract][Full Text] [Related]
25. Myocardial collagen remodeling in pressure overload hypertrophy. A case for interstitial heart disease. Weber KT; Jalil JE; Janicki JS; Pick R Am J Hypertens; 1989 Dec; 2(12 Pt 1):931-40. PubMed ID: 2532916 [TBL] [Abstract][Full Text] [Related]
26. Renal denervation mitigates cardiac remodeling and renal damage in Dahl rats: a comparison with β-receptor blockade. Watanabe H; Iwanaga Y; Miyaji Y; Yamamoto H; Miyazaki S Hypertens Res; 2016 Apr; 39(4):217-26. PubMed ID: 26631854 [TBL] [Abstract][Full Text] [Related]
27. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?]. Brilla CG; Schencking M; Scheer C; Rupp H Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851 [TBL] [Abstract][Full Text] [Related]
28. Comparative efficacy of a DA2/alpha2 agonist and a beta-blocker in reducing adrenergic drive and cardiac fibrosis in an experimental model of left ventricular dysfunction after coronary artery occlusion. Latini R; Masson S; Jeremic G; Luvarà G; Fiordaliso F; Calvillo L; Bernasconi R; Torri M; Rondelli I; Razzetti R; Bongrani S J Cardiovasc Pharmacol; 1998 Apr; 31(4):601-8. PubMed ID: 9554811 [TBL] [Abstract][Full Text] [Related]
29. Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload. Kuster GM; Kotlyar E; Rude MK; Siwik DA; Liao R; Colucci WS; Sam F Circulation; 2005 Feb; 111(4):420-7. PubMed ID: 15687129 [TBL] [Abstract][Full Text] [Related]
30. Altered left ventricular remodeling with beta-adrenergic blockade and exercise after coronary reperfusion in rats. Oh BH; Ono S; Gilpin E; Ross J Circulation; 1993 Feb; 87(2):608-16. PubMed ID: 8093867 [TBL] [Abstract][Full Text] [Related]
31. Pharmacologic inhibition of the enzymatic effects of tissue transglutaminase reduces cardiac fibrosis and attenuates cardiomyocyte hypertrophy following pressure overload. Shinde AV; Su Y; Palanski BA; Fujikura K; Garcia MJ; Frangogiannis NG J Mol Cell Cardiol; 2018 Apr; 117():36-48. PubMed ID: 29481819 [TBL] [Abstract][Full Text] [Related]
32. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice. Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839 [TBL] [Abstract][Full Text] [Related]
33. Effects of salt loading and various therapies on cardiac hypertrophy and fibrosis in young spontaneously hypertensive rats. Ziegelhöffer-Mihalovicova B; Arnold N; Marx G; Tannapfel A; Zimmer HG; Rassler B Life Sci; 2006 Jul; 79(9):838-46. PubMed ID: 16624325 [TBL] [Abstract][Full Text] [Related]
34. FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy. Zhang Y; Edgley AJ; Cox AJ; Powell AK; Wang B; Kompa AR; Stapleton DI; Zammit SC; Williams SJ; Krum H; Gilbert RE; Kelly DJ Eur J Heart Fail; 2012 May; 14(5):549-62. PubMed ID: 22417655 [TBL] [Abstract][Full Text] [Related]
35. Sympathetic alpha(2)-adrenoceptors prevent cardiac hypertrophy and fibrosis in mice at baseline but not after chronic pressure overload. Gilsbach R; Schneider J; Lother A; Schickinger S; Leemhuis J; Hein L Cardiovasc Res; 2010 Jun; 86(3):432-42. PubMed ID: 20083574 [TBL] [Abstract][Full Text] [Related]
36. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure. Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123 [TBL] [Abstract][Full Text] [Related]
37. Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice. Heymans S; Lupu F; Terclavers S; Vanwetswinkel B; Herbert JM; Baker A; Collen D; Carmeliet P; Moons L Am J Pathol; 2005 Jan; 166(1):15-25. PubMed ID: 15631996 [TBL] [Abstract][Full Text] [Related]
38. Transgenic expression of matrix metalloproteinase-1 inhibits myocardial fibrosis and prevents the transition to heart failure in a pressure overload mouse model. Foronjy RF; Sun J; Lemaitre V; D'Armiento JM Hypertens Res; 2008 Apr; 31(4):725-35. PubMed ID: 18633185 [TBL] [Abstract][Full Text] [Related]
39. Sympathectomy and cardiovascular spectral components in conscious normotensive rats. Daffonchio A; Franzelli C; Radaelli A; Castiglioni P; Di Rienzo M; Mancia G; Ferrari AU Hypertension; 1995 Jun; 25(6):1287-93. PubMed ID: 7768575 [TBL] [Abstract][Full Text] [Related]